Global Bio-Pharmaceutical Logistics Market Outlook 2020
Healthcare value chain has been continuously evolving with core drug manufacturers opting for cost optimization of supply chain by outsourcing distribution services to vendors. Transportation of drugs under stringent norms has streamlined distribution in the pharmaceutical industry emphasizing on outsourcing to third party vendors. The report “Global Bio-Pharmaceutical Logistics Market Outlook 2022” provides an in-depth analysis of global bio-pharmaceutical logistics market, focusing on cold-chain and non-cold chain distribution.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities at the global and regional level. The report has been segmented as following:-
Market Segmentation
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities at the global and regional level. The report has been segmented as following:-
Market Segmentation
- Cold-chain Logistics
- Non-Cold Chain Logistics
- Europe
- North America
- Asia Pacific
- Rest of World
- Kuehne + Nagel
- FedEx Corporation
- Bio Pharma Logistics
- DB Schenket
- Deutsche Post DHL Group
1. EXECUTIVE SUMMARY
2. RESEARCH METHODOLOGY
3. BIO-PHARMACEUTICAL LOGISTICS
3.1 Introduction
3.2 Industry Chain Structure of Bio-Pharmaceutical Logistics
3.3 The Evolving Pharmaceutical Distribution Model
4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET ANALYSIS
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share
4.2.1 By Segments (Actual & Forecasted)
4.2.2 By Spending-Breakdown
4.2.3 By Mode of Transport
4.2.4 By Product Type
5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION
5.1 Cold-Chain Logistics
5.1.1 Overview
5.1.2 Market Analysis
5.1.3 Market Share by Cost
5.2 Non-Cold Chain Logistics
5.2.1 Overview
5.2.2 Market Analysis
5.2.3 Market Share by Cost
6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET- REGIONAL ANALYSIS
6.1 Europe
6.1.1 Overview
6.1.2 Market Analysis
6.2 North America
6.2.1 Overview
6.2.2 Market Analysis
6.3 Asia Pacific
6.3.1 Overview
6.3.2 Market Analysis
6.4 Rest of World
6.4.1 Overview
6.4.2 Market Analysis
7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET DYNAMICS
7.1 Industry Trends & Development
7.1.1 Focus on Inventory Visibility
7.1.3 Evolving Pharmaceutical Packaging
7.1.5 Integrated Logistics Solutions for Pharmaceutical Industry
7.1.7 Deployment of IoT Enabled Platform
7.2 Growth Drivers
7.2.1 Growth of Global Pharmaceutical Market
7.2.2 Rise in Clinical Trial Logistics Spending
7.2.3 Development of Biologically Based Products
7.2.4 Focus on Quality and Product Sensitivity
7.2.5 Regulations on Production and Supply Chains
7.3 Challenges
7.3.1 Temperature Control
7.3.2 Regulatory Compliance
7.3.3 Security and Safety of Inventory
8. COMPETITIVE LANDSCAPE
9. COMPANY PROFILES
9.1 Kuehne + Nagel
9.1.1 Business Overview
9.1.2 Healthcare Solutions
9.1.3 Financial Analysis
9.2 FedEx Corporation
9.2.1 Business Overview
9.2.2 Healthcare Solutions
9.2.3 Financial Analysis
9.3 Bio Pharma Logistics
9.3.1 Business Overview
9.3.2 Healthcare Solutions
9.3.3 Financial Analysis
9.4 DB Schenker
9.4.1 Business Overview
9.4.2 Healthcare Solutions
9.4.3 Financial Analysis
9.5 Deutsche Post DHL Group
9.5.1 Business Overview
9.5.2 Healthcare Solutions
9.5.3 Financial Analysis
2. RESEARCH METHODOLOGY
3. BIO-PHARMACEUTICAL LOGISTICS
3.1 Introduction
3.2 Industry Chain Structure of Bio-Pharmaceutical Logistics
3.3 The Evolving Pharmaceutical Distribution Model
4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET ANALYSIS
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share
4.2.1 By Segments (Actual & Forecasted)
4.2.2 By Spending-Breakdown
4.2.3 By Mode of Transport
4.2.4 By Product Type
5. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION
5.1 Cold-Chain Logistics
5.1.1 Overview
5.1.2 Market Analysis
5.1.3 Market Share by Cost
5.2 Non-Cold Chain Logistics
5.2.1 Overview
5.2.2 Market Analysis
5.2.3 Market Share by Cost
6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET- REGIONAL ANALYSIS
6.1 Europe
6.1.1 Overview
6.1.2 Market Analysis
6.2 North America
6.2.1 Overview
6.2.2 Market Analysis
6.3 Asia Pacific
6.3.1 Overview
6.3.2 Market Analysis
6.4 Rest of World
6.4.1 Overview
6.4.2 Market Analysis
7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET DYNAMICS
7.1 Industry Trends & Development
7.1.1 Focus on Inventory Visibility
7.1.3 Evolving Pharmaceutical Packaging
7.1.5 Integrated Logistics Solutions for Pharmaceutical Industry
7.1.7 Deployment of IoT Enabled Platform
7.2 Growth Drivers
7.2.1 Growth of Global Pharmaceutical Market
7.2.2 Rise in Clinical Trial Logistics Spending
7.2.3 Development of Biologically Based Products
7.2.4 Focus on Quality and Product Sensitivity
7.2.5 Regulations on Production and Supply Chains
7.3 Challenges
7.3.1 Temperature Control
7.3.2 Regulatory Compliance
7.3.3 Security and Safety of Inventory
8. COMPETITIVE LANDSCAPE
9. COMPANY PROFILES
9.1 Kuehne + Nagel
9.1.1 Business Overview
9.1.2 Healthcare Solutions
9.1.3 Financial Analysis
9.2 FedEx Corporation
9.2.1 Business Overview
9.2.2 Healthcare Solutions
9.2.3 Financial Analysis
9.3 Bio Pharma Logistics
9.3.1 Business Overview
9.3.2 Healthcare Solutions
9.3.3 Financial Analysis
9.4 DB Schenker
9.4.1 Business Overview
9.4.2 Healthcare Solutions
9.4.3 Financial Analysis
9.5 Deutsche Post DHL Group
9.5.1 Business Overview
9.5.2 Healthcare Solutions
9.5.3 Financial Analysis
